[1]
Pan, J. et al. 2025. Unveiling CCL2 and CXCL1: Key biomarkers and therapeutic targets in idiopathic pulmonary fibrosis. Sarcoidosis, Vasculitis and Diffuse Lung Diseases. 42, 4 (Dec. 2025), 17182. DOI:https://doi.org/10.36141/svdld.v42i4.17182.